{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,15]],"date-time":"2026-07-15T13:49:33Z","timestamp":1784123373382,"version":"3.55.0"},"reference-count":56,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,3,1]],"date-time":"2020-03-01T00:00:00Z","timestamp":1583020800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,3,1]],"date-time":"2020-03-01T00:00:00Z","timestamp":1583020800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100004681","name":"Higher Education Commission, Pakistan","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004681","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioorganic Chemistry"],"published-print":{"date-parts":[[2020,3]]},"DOI":"10.1016\/j.bioorg.2020.103567","type":"journal-article","created":{"date-parts":[[2020,1,5]],"date-time":"2020-01-05T21:15:37Z","timestamp":1578258937000},"page":"103567","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":28,"special_numbering":"C","title":["Synthesis and evaluation of novel S-benzyl- and S-alkylphthalimide- oxadiazole -benzenesulfonamide hybrids as inhibitors of dengue virus protease"],"prefix":"10.1016","volume":"96","author":[{"given":"Syeda Shamila","family":"Hamdani","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bilal Ahmad","family":"Khan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shahid","family":"Hameed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Farwa","family":"Batool","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hafiza Nosheen","family":"Saleem","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ehsan Ullah","family":"Mughal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muhammad","family":"Saeed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bioorg.2020.103567_b0005","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1038\/nature12060","article-title":"The global distribution and burden of dengue","volume":"496","author":"Bhatt","year":"2013","journal-title":"Nature"},{"key":"10.1016\/j.bioorg.2020.103567_b0010","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.f6280","article-title":"Burden of dengue fever is higher than previously thought","volume":"347","author":"Gulland","year":"2013","journal-title":"BMJ"},{"key":"10.1016\/j.bioorg.2020.103567_b0015","doi-asserted-by":"crossref","first-page":"e101","DOI":"10.1016\/S1473-3099(16)30518-7","article-title":"Epidemic arboviral diseases: priorities for research and public health","volume":"17","author":"Wilder-Smith","year":"2017","journal-title":"Lancet Infect. Dis."},{"key":"10.1016\/j.bioorg.2020.103567_b0020","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.coph.2016.06.002","article-title":"Towards antiviral therapies for treating dengue virus infections","volume":"30","author":"Kaptein","year":"2016","journal-title":"Curr. Opinion Pharmacol."},{"key":"10.1016\/j.bioorg.2020.103567_b0025","doi-asserted-by":"crossref","first-page":"2395","DOI":"10.1073\/pnas.91.7.2395","article-title":"Dengue: the risk to developed and developing countries","volume":"91","author":"Monath","year":"1994","journal-title":"Proc. Nat. Acad. Sci. United States of America"},{"key":"10.1016\/j.bioorg.2020.103567_b0030","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.mjafi.2014.09.011","article-title":"Discovery of fifth serotype of dengue virus (DENV-5): a new public health dilemma in dengue control","volume":"71","author":"Mustafa","year":"2015","journal-title":"Med. J. Armed. Forces India"},{"key":"10.1016\/j.bioorg.2020.103567_b0035","doi-asserted-by":"crossref","unstructured":"M.R. Capeding, N.H. Tran, S.R. Hadinegoro, H.I. Ismail, T. Chotpitayasunondh, M.N. Chua, C.Q. Luong, K. Rusmil, D.N. Wirawan, R. Nallusamy, P. Pitisuttithum, U. Thisyakorn, I.K. Yoon, D. van der Vliet, E. Langevin, T. Laot, Y. Hutagalung, C. Frago, M. Boaz, T.A. Wartel, N.G. Tornieporth, M. Saville, A. Bouckenooghe, C.Y.D.S. Group, Clinical efficacy and safety of a novel tetravalent dengue vaccine in healthy children in Asia: a phase 3, randomised, observer-masked, placebo-controlled trial, Lancet 384 (2014) 1358\u20131365.","DOI":"10.1016\/S0140-6736(14)61060-6"},{"key":"10.1016\/j.bioorg.2020.103567_b0040","doi-asserted-by":"crossref","unstructured":"S.R. Hadinegoro, J.L. Arredondo-Garcia, M.R. Capeding, C. Deseda, T. Chotpitayasunondh, R. Dietze, H.I. Muhammad Ismail, H. Reynales, K. Limkittikul, D.M. Rivera-Medina, H.N. Tran, A. Bouckenooghe, D. Chansinghakul, M. Cortes, K. Fanouillere, R. Forrat, C. Frago, S. Gailhardou, N. Jackson, F. Noriega, E. Plennevaux, T.A. Wartel, B. Zambrano, M. Saville, C.-T.D.V.W. Group, Efficacy and long-term safety of a dengue vaccine in regions of endemic disease, New England J. Med. 373 (2015) 1195\u20131206.","DOI":"10.1056\/NEJMoa1506223"},{"key":"10.1016\/j.bioorg.2020.103567_b0045","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.jclinepi.2017.11.019","article-title":"Controversy and debate on dengue vaccine-paper 3: final response to Review of a licensed dengue vaccine: inappropriate subgroup analyses and selective reporting may cause harm in mass vaccination programs","volume":"95","author":"Dans","year":"2018","journal-title":"J. Clin. Epidemiol."},{"key":"10.1016\/j.bioorg.2020.103567_b0050","unstructured":"M. Mogato, Philippines says anti-dengue vaccine may be connected to three deaths, in: Reuters, Thomson Reuters, United States, 2018."},{"key":"10.1016\/j.bioorg.2020.103567_b0055","doi-asserted-by":"crossref","first-page":"5622","DOI":"10.1021\/acs.jmedchem.5b01653","article-title":"The medicinal chemistry of dengue virus","volume":"59","author":"Behnam","year":"2016","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2020.103567_b0060","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1016\/j.ejmech.2018.07.014","article-title":"Potential targets for therapeutic intervention and structure based vaccine design against Zika virus","volume":"156","author":"Qadir","year":"2018","journal-title":"Europ. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2020.103567_b0065","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1007\/978-981-10-8727-1_13","article-title":"Strategies towards protease inhibitors for emerging flaviviruses","volume":"1062","author":"Nitsche","year":"2018","journal-title":"Adv. Exp. Med. Biol."},{"key":"10.1016\/j.bioorg.2020.103567_b0070","doi-asserted-by":"crossref","first-page":"11348","DOI":"10.1021\/cr500233q","article-title":"Biochemistry and medicinal chemistry of the dengue virus protease","volume":"114","author":"Nitsche","year":"2014","journal-title":"Chem. Rev."},{"key":"10.1016\/j.bioorg.2020.103567_b0075","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1007\/s00705-017-3641-5","article-title":"Pharmacophoric characteristics of dengue virus NS2B\/NS3pro inhibitors: a systematic review of the most promising compounds","volume":"163","author":"Leonel","year":"2018","journal-title":"Arch. Virol."},{"key":"10.1016\/j.bioorg.2020.103567_b0080","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/j.bbrc.2013.09.078","article-title":"A small compound targeting the interaction between nonstructural proteins 2B and 3 inhibits dengue virus replication","volume":"440","author":"Pambudi","year":"2013","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.bioorg.2020.103567_b0085","doi-asserted-by":"crossref","first-page":"4492","DOI":"10.1016\/j.bmcl.2009.03.172","article-title":"An efficient synthesis and biological study of novel indolyl-1,3,4-oxadiazoles as potent anticancer agents","volume":"19","author":"Kumar","year":"2009","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.bioorg.2020.103567_b0090","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/S0014-827X(00)00056-2","article-title":"Synthesis and evaluation of antimitotic activity of alkylated 2-amino-1, 3, 4-oxadiazole derivatives","volume":"55","author":"Rai","year":"2000","journal-title":"Il Farmaco"},{"key":"10.1016\/j.bioorg.2020.103567_b0095","doi-asserted-by":"crossref","first-page":"1802","DOI":"10.1021\/jm00065a002","article-title":"1, 3, 4-Oxadiazole, 1, 3, 4-thiadiazole, and 1, 2, 4-triazole analogs of the fenamates: in vitro inhibition of cyclooxygenase and 5-lipoxygenase activities","volume":"36","author":"Boschelli","year":"1993","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2020.103567_b0100","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1021\/jm00060a017","article-title":"Design of 5-(3, 5-di-tert-butyl-4-hydroxyphenyl)-1, 3, 4-thiadiazoles,-1, 3, 4-oxadiazoles, and-1, 2, 4-triazoles as orally active, nonulcerogenic antiinflammatory agents","volume":"36","author":"Mullican","year":"1993","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2020.103567_b0105","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1002\/jps.2600820210","article-title":"Substituted thiosemicarbazides and corresponding cyclized 1, 3, 4-oxadiazoles and their anti-inflammatory activity","volume":"82","author":"Raman","year":"1993","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.bioorg.2020.103567_b0110","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/S0014-827X(01)01176-4","article-title":"Synthesis and anti-inflammatory activity of 1-acylthiosemicarbazides, 1, 3, 4-oxadiazoles, 1, 3, 4-thiadiazoles and 1, 2, 4-triazole-3-thiones","volume":"57","author":"Palaska","year":"2002","journal-title":"Il Farmaco"},{"key":"10.1016\/j.bioorg.2020.103567_b0115","doi-asserted-by":"crossref","first-page":"1822","DOI":"10.1016\/j.bmc.2007.11.014","article-title":"Design, synthesis and evaluation of antiinflammatory, analgesic and ulcerogenicity studies of novel S-substituted phenacyl-1, 3, 4-oxadiazole-2-thiol and Schiff bases of diclofenac acid as nonulcerogenic derivatives","volume":"16","author":"Bhandari","year":"2008","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.bioorg.2020.103567_b0120","doi-asserted-by":"crossref","unstructured":"V. Adhikari, V. Badiger, Synthesis and biological activities of isoxazolo (5, 4\u2010d) pyrimidinyloxymethyl\u2010thiadiazoles,\u2010oxadiazoles and\u2010triazoles, ChemInform 19 (1988).","DOI":"10.1002\/chin.198847189"},{"key":"10.1016\/j.bioorg.2020.103567_b0125","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1002\/jhet.5570070308","article-title":"2-Phenyl-5-(trichloromethyl)-1, 3, 4-oxadiazoles, A new class of antimalarial substances","volume":"7","author":"Hutt","year":"1970","journal-title":"J. Heterocyclic Chem."},{"key":"10.1016\/j.bioorg.2020.103567_b0130","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1002\/ardp.19833160603","article-title":"Synthesis of some new substituted 1, 3, 4-oxadiazoles as potential insecticidal, antibacterial and anti-acetylcholine esterase agents","volume":"316","author":"Misra","year":"1983","journal-title":"Archiv der Pharmazie"},{"key":"10.1016\/j.bioorg.2020.103567_b0135","first-page":"17","article-title":"Studies in oxadiazoles synthesis of some 2-mercapto-l, 3, 4-oxadiazoles and related compounds as potential fungicides","volume":"40","author":"Giri","year":"1976","journal-title":"Agric. Biol. Chem."},{"key":"10.1016\/j.bioorg.2020.103567_b0140","first-page":"759","article-title":"Synthesis of some 5-aryl-2-heteroaryl\/heteroarylamino-l, 3, 4-oxadiazoles as potential fungicides","volume":"40","author":"Singh","year":"1976","journal-title":"Agric. Biol. Chem."},{"key":"10.1016\/j.bioorg.2020.103567_b0145","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.bioorg.2017.07.009","article-title":"Synthesis, \u03b1-glucosidase inhibitory activity and in silico study of tris-indole hybrid scaffold with oxadiazole ring: as potential leads for the management of type-II diabetes mellitus","volume":"74","author":"Taha","year":"2017","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.bioorg.2020.103567_b0150","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/j.bioorg.2017.12.001","article-title":"Oxindole based oxadiazole hybrid analogs: novel \u03b1-glucosidase inhibitors","volume":"76","author":"Taha","year":"2018","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.bioorg.2020.103567_b0155","doi-asserted-by":"crossref","unstructured":"A. Pac, S. Buscemi, A. Palumbo, P.I. Pibiri, Recent advances in the chemistry of 1,2,4-oxadiazoles 116 (2015) 85\u2013130.","DOI":"10.1016\/bs.aihch.2015.05.001"},{"key":"10.1016\/j.bioorg.2020.103567_b0160","doi-asserted-by":"crossref","first-page":"4155","DOI":"10.1016\/j.bmc.2015.06.060","article-title":"Synthesis of new oxadiazole derivatives as \u03b1-glucosidase inhibitors","volume":"23","author":"Taha","year":"2015","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.bioorg.2020.103567_b0165","doi-asserted-by":"crossref","first-page":"1817","DOI":"10.1021\/jm2013248","article-title":"Oxadiazoles in medicinal chemistry","volume":"55","author":"Bostr\u00f6m","year":"2012","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2020.103567_b0170","doi-asserted-by":"crossref","first-page":"7394","DOI":"10.1016\/j.bmc.2015.10.037","volume":"23","author":"Taha","year":"2015","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.bioorg.2020.103567_b0175","first-page":"435","article-title":"Vitor, lima, marco, 1,2,4- and 1,3,4-oxadiazoles as scaffolds in the development of antiparasitic agents","volume":"29","author":"Santos","year":"2018","journal-title":"J. Braz. Chem. Soc."},{"key":"10.1016\/j.bioorg.2020.103567_b0180","first-page":"644","article-title":"Synthesis of N-(2-Naphthyloxyacetyl) thiosemicarbazides and 2-arylamino-5-(2-naphthyloxymethyl)-1, 3, 4-thiadiazoles\/oxadiazoles as oral hypoglycemic agents","author":"Husain","year":"1986","journal-title":"Curr. Sci."},{"key":"10.1016\/j.bioorg.2020.103567_b0185","doi-asserted-by":"crossref","first-page":"6057","DOI":"10.1016\/j.bmcl.2004.09.072","article-title":"Synthesis and anticonvulsant activity of new 2-substituted-5-[2-(2-fluorophenoxy) phenyl]-1, 3, 4-oxadiazoles and 1, 2, 4-triazoles","volume":"14","author":"Almasirad","year":"2004","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.bioorg.2020.103567_b0190","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1146\/annurev.pa.16.040176.001521","article-title":"Relatons between structure and biological activity of sulfonamides","volume":"16","author":"Maren","year":"1976","journal-title":"Ann. Rev. Pharmacol. Toxicol."},{"key":"10.1016\/j.bioorg.2020.103567_b0195","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1021\/ml400217r","article-title":"Novel peptidomimetic hepatitis C virus NS3\/4A protease inhibitors spanning the P2\u2013P1' region","volume":"5","author":"Lampa","year":"2014","journal-title":"ACS Med. Chem. Lett."},{"key":"10.1016\/j.bioorg.2020.103567_b0200","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1016\/S0968-0896(99)00021-8","article-title":"Increased stability of peptidesulfonamide peptidomimetics towards protease catalyzed degradation","volume":"7","author":"de Bont","year":"1999","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.bioorg.2020.103567_b0205","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.bioorg.2015.07.005","article-title":"Synthesis and molecular modelling studies of novel sulphonamide derivatives as dengue virus 2 protease inhibitors","volume":"62","author":"Timiri","year":"2015","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.bioorg.2020.103567_b0210","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.ejmech.2016.04.008","article-title":"Progress and prospects on DENV protease inhibitors","volume":"117","author":"Timiri","year":"2016","journal-title":"Europ. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2020.103567_b0215","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1080\/14756366.2017.1355791","article-title":"Inhibition of dengue virus replication by novel inhibitors of RNA-dependent RNA polymerase and protease activities","volume":"32","author":"Pelliccia","year":"2017","journal-title":"J. Enzyme Inhibit. Med. Chem."},{"key":"10.1016\/j.bioorg.2020.103567_b0220","doi-asserted-by":"crossref","first-page":"275","DOI":"10.4103\/0250-474X.106077","article-title":"Synthesis, antiviral and cytotoxicity studies of novel N-substituted indophenazine derivatives","volume":"74","author":"Selvam","year":"2012","journal-title":"Indian J. Pharm. Sci."},{"key":"10.1016\/j.bioorg.2020.103567_b0225","doi-asserted-by":"crossref","first-page":"4149","DOI":"10.1016\/j.bmc.2012.04.060","article-title":"Synthesis and antimycobacterial activity of some phthalimide derivatives","volume":"20","author":"Akg\u00fcn","year":"2012","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.bioorg.2020.103567_b0230","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0116135","article-title":"A novel phthalimide derivative, TC11, has preclinical effects on high-risk myeloma cells and osteoclasts","volume":"10","author":"Matsushita","year":"2015","journal-title":"PloS One"},{"key":"10.1016\/j.bioorg.2020.103567_b0235","doi-asserted-by":"crossref","first-page":"2535","DOI":"10.1016\/j.bmc.2012.02.055","article-title":"Synthesis of new sulfonamides as lipoxygenase inhibitors","volume":"20","author":"Mustafa","year":"2012","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.bioorg.2020.103567_b0240","doi-asserted-by":"crossref","first-page":"141","DOI":"10.3998\/ark.5550190.0009.216","article-title":"Synthesis and antimicrobial activity of some derivatives of acylhydrazine including novel benzenediazasulfonamides","author":"Zareef","year":"2008","journal-title":"Arkivoc"},{"key":"10.1016\/j.bioorg.2020.103567_b0245","doi-asserted-by":"crossref","first-page":"3079","DOI":"10.1139\/v72-489","article-title":"Five-membered heterocyclic thiones. Part I. 1, 3, 4-Oxadiazole-2-thione","volume":"50","author":"Horning","year":"1972","journal-title":"Can. J. Chem."},{"key":"10.1016\/j.bioorg.2020.103567_b0250","doi-asserted-by":"crossref","first-page":"668","DOI":"10.3109\/14756366.2010.546792","article-title":"Synthesis, QSAR and anti-HIV activity of new 5-benzylthio-1,3,4-oxadiazoles derived from alpha-amino acids","volume":"26","author":"Syed","year":"2011","journal-title":"J. Enzyme Inhibit. Med. Chem."},{"key":"10.1016\/j.bioorg.2020.103567_b0255","doi-asserted-by":"crossref","first-page":"1346","DOI":"10.2174\/1570180815666180326152204","article-title":"Design and synthesis of novel 1,3,4-oxadiazole derivatives bearing azo moiety as biologically significant scaffolds","volume":"15","author":"Khan","year":"2018","journal-title":"Lett. Drug Des. Discovery"},{"key":"10.1016\/j.bioorg.2020.103567_b0260","doi-asserted-by":"crossref","first-page":"4587","DOI":"10.1016\/j.ejmech.2010.07.021","article-title":"Synthesis and biological property of some novel 1,3,4-oxadiazoles","volume":"45","author":"Ramaprasad","year":"2010","journal-title":"Europ. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2020.103567_b0265","doi-asserted-by":"crossref","first-page":"45762","DOI":"10.1074\/jbc.M107360200","article-title":"Activity of recombinant dengue 2 virus NS3 protease in the presence of a truncated NS2B co-factor, small peptide substrates, and inhibitors","volume":"276","author":"Leung","year":"2001","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bioorg.2020.103567_b0270","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1002\/jcc.21334","article-title":"AutoDock Vina: improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading","volume":"31","author":"Trott","year":"2010","journal-title":"J. Comput. Chem."},{"key":"10.1016\/j.bioorg.2020.103567_b0275","doi-asserted-by":"crossref","first-page":"6832","DOI":"10.1021\/jacs.9b02505","article-title":"Discovery, X-ray crystallography and antiviral activity of allosteric inhibitors of flavivirus NS2B-NS3 Protease","volume":"141","author":"Yao","year":"2019","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.bioorg.2020.103567_b0280","doi-asserted-by":"crossref","first-page":"1525","DOI":"10.1021\/acsomega.8b02861","article-title":"Inhibition of dengue virus protease by eugeniin, isobiflorin, and biflorin isolated from the flower buds of syzygium aromaticum (cloves)","volume":"4","author":"Saleem","year":"2019","journal-title":"ACS Omega"}],"container-title":["Bioorganic Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206819313641?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206819313641?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,23]],"date-time":"2025-09-23T08:03:39Z","timestamp":1758614619000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0045206819313641"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,3]]},"references-count":56,"alternative-id":["S0045206819313641"],"URL":"https:\/\/doi.org\/10.1016\/j.bioorg.2020.103567","relation":{},"ISSN":["0045-2068"],"issn-type":[{"value":"0045-2068","type":"print"}],"subject":[],"published":{"date-parts":[[2020,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Synthesis and evaluation of novel S-benzyl- and S-alkylphthalimide- oxadiazole -benzenesulfonamide hybrids as inhibitors of dengue virus protease","name":"articletitle","label":"Article Title"},{"value":"Bioorganic Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bioorg.2020.103567","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"103567"}}